Venoactive medications and the place of Daflon 500 mg in recent guidelines on the management of chronic venous disease

被引：0

作者：

Nicolaides, Andrew ^{[1
]}

机构：

[1] Vasc Screening & Diagnost Ctr, 2 Kyriacou Matsi St, CY-2368 Nicosia, Cyprus

来源：

PHLEBOLYMPHOLOGY | 2009年 / 16卷 / 04期

关键词：

chronic venous disease; venoactive drugs; guidelines; Daflon; 500; mg;

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Because the venous system is in many respects more complex than the arterial system, because chronic venous disease (CVD) is common in Western populations, and because both specialists and general practitioners have to deal with this disease, there is a need for practical support regarding CVD management in daily practice. This article summarizes the most recent guidelines regarding the place of venoactive drugs (VADs) such as Daflon 500 mg in the management of this disease. In addition, it makes suggestions regarding expected improvements in future guideline documents.

引用

页码：340 / 346

页数：7

共 50 条

[41] A snapshot of venous ultrasound examinations in Australia and New Zealand: Implications for diagnosis and management of chronic venous disease interventions
Liu, Gaorui
Clarke, Jillian L.
Mohan, Irwin
ULTRASOUND, 2022, 30 (03) : 236 - 245
[42] Patients with chronic venous insufficiency in the COVID-19 era and thrombotic risk-guidelines for conservative patient management resulting from the basics of pathophysiology
Krasinski, Zbigniew
Krasinska, Aleksandra
Markiewicz, Szymon
Zielinski, Maciej
POLISH JOURNAL OF SURGERY, 2021, 93 (02) : 42 - 51
[43] Comparison of the Recent Updates to the ACC/AHA and ESC Guidelines for the Management of Valvular Heart Disease: Similarities and Differences
Laskar, Nabila
Badiani, Sveeta
Treibel, Thomas
Bhattacharyya, Sanjeev
Lloyd, Guy
CURRENT CARDIOLOGY REPORTS, 2023, 25 (03) : 147 - 156
[44] Comparison of the Recent Updates to the ACC/AHA and ESC Guidelines for the Management of Valvular Heart Disease: Similarities and Differences
Nabila Laskar
Sveeta Badiani
Thomas Treibel
Sanjeev Bhattacharyya
Guy Lloyd
Current Cardiology Reports, 2023, 25 : 147 - 156
[45] VEIN STEP: Chronic VEnous disorders maNagement and Treatment Effectiveness Evaluation in Chronic Venous Disease, an International Observational Prospective Study. Results from Morocco
Zoubida, Tazi Mezalek
Ulloa, Jorge Hernando
PHLEBOLYMPHOLOGY, 2021, 28 (02) : 68 - 78
[46] Multicentre audit of inpatient management of acute exacerbations of chronic obstructive pulmonary disease: comparison with clinical guidelines
Pretto, J. J.
McDonald, V. M.
Wark, P. A. B.
Hensley, M. J.
INTERNAL MEDICINE JOURNAL, 2012, 42 (04) : 380 - 387
[47] Expert consensus on the conservative management of patients with chronic venous disease in CEAP clinical classes C0s-C3 in Italy
Vitale, Cristiana
Lucchi, Massimo
Bissacco, Daniele
Bilancini, Salvino
D'Abate, Fabrizio
Santoliquido, Angelo
PHLEBOLOGY, 2020, 35 (05) : 316 - 324
[48] The Saudi Thoracic Society Evidence-based guidelines for the diagnosis and management of chronic obstructive pulmonary disease
Al-Jahdali, Hamdan
Al-Lehebi, Riyad
Lababidi, Hani
Alhejaili, Faris F.
Habis, Yahya
Alsowayan, Waleed A.
Idrees, Majdy M.
Zeitouni, Mohammed O.
Alshimemeri, Abdullah
Al Ghobain, Mohammed
Alaraj, Ali
Alhamad, Esam H.
ANNALS OF THORACIC MEDICINE, 2025, 20 (01) : 1 - 35
[49] Veno-active drugs in the management of chronic venous disease. An international consensus statement: Current medical position, prospective views and final resolution
Ramelet, AA
Boisseau, MR
Allegra, C
Nicolaides, A
Jaeger, K
Carpentier, P
Cappelli, R
Forconi, S
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2005, 33 (04) : 309 - 319
[50] Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
Gourdy, Pierre
Schiele, Francois
Halimi, Jean-Michel
Kownator, Serge
Hadjadj, Samy
Valensi, Paul
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10

← 1 2 3 4 5 →